| Literature DB >> 28388241 |
Yelenca Ortega Zamora1, Leidy Johana Escamilla Rojas1, Elvis Mayron Villa Sandoval1, Joan Steven Vela Porras1, Edgar Yarleison Cossio Contrera1, Sergio Sebastian Cubides Romero1, Pedro David Carreño Ramirez1, Hermes Urriago Losada1, Carolina De Los Rios1, Daniela Alejandra Gomez Mahecha1, Karen Daniela Lovera Serrano1, Juan Carlos Barreto Montaña1, Viviana Lorena Narvaez Caicedo1, Fredy R S Gutierrez1.
Abstract
Introduction: Chagas disease (CD) is caused by a parasitic infection. The disease usually occurs after decades of the primary infection and can involve the myocardium or the digestive system. Of note, around 30% of T. cruzi infected patients develop CD while the other 70% may remain asymptomatic for their entire life. CD is usually observed as familial clustered phenomena. Moreover, individuals with chronic Chagas heart disease (CCHD) usually present a strong, deregulated immune response, which strongly suggests an immunogenetic effect.Areas covered: In this article we review and discuss the information currently available from the published scientific literature regarding the genetic variants of molecules of the immune system that contribute to the clinical presentation of the disease.Expert commentary: Of note, the most promissory results are found on the polymorphisms of chemokine receptors, particularly CCR5 and CCR2. Additional investigations are required, particularly with a focus on the genes that regulate the immune system.Entities:
Keywords: Chagas; biomarkers; cardiomyopathy; immunogenetics; parasitic
Year: 2017 PMID: 28388241 DOI: 10.1080/14779072.2017.1317591
Source DB: PubMed Journal: Expert Rev Cardiovasc Ther ISSN: 1477-9072